Dr. Trabulsi Edouard Trabulsi, M.D.

Contact Dr. Trabulsi

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Medical School
State University of New York at Buffalo, 1995

Residency
General Surgery, Thomas Jefferson University, 1997
Urology, Thomas Jefferson University, 2001

Fellowship
Fellow in Urologic Oncology, Memorial Sloan-Kettering Cancer Center, 2003
Fellow in Minimally Invasive Urologic Oncology, Memorial Sloan-Kettering Cancer Center, 2004

Board Certification
American Board of Urology, 2005

University Appointment
Associate Professor
Director of Minimally Invasive Urologic Oncology
Director of Clinical Trials
Director, Multidisciplinary Genito-Urinary Cancer Clinic, Kimmel Cancer Center
Co-Director, Jefferson Prostate Diagnostic Center

Hospital Appointment

Research and Clinical Interests
Dr. Trabulsi is Director of Minimally Invasive Urologic Oncology, as well as Director of Clinical Trials, in the Department of Urology, Jefferson Medical College at Thomas Jefferson University. He is also the Director of the Genito-Urinary Multidisciplinary Cancer Clinic, Kimmel Cancer Center at Jefferson.

Dr. Trabulsi's research and clinical interests include prostate cancer, kidney cancer, bladder cancer and testicular cancer. He is the author of numerous abstracts, manuscripts and book chapters.

Dr. Trabulsi focuses on all aspects of urologic oncology, including prostate cancer, bladder cancer, kidney cancer, testicular cancer.

Dr. Trabulsi performs minimally invasive urologic oncology procedures, including robotic-assisted laparoscopic radical prostatectomy, laparoscopic nephrectomy, laparoscopic partial nephrectomy, and laparoscopic cryosurgical ablation of kidney tumors.

Publications

Most recent Peer-reviewed Publications

  1. STAT5A/B gene locus undergoes amplification during human prostate cancer progression
  2. Targeting cell cycle and hormone receptor pathways in cancer
  3. Salvage radiotherapy for prostate cancer: Finding a way forward using radiobiological modeling
  4. Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: A prospective study of 1,962 cases
  5. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: A randomized, double-blind trial of dutasteride pretreatment
  6. Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008: A population-based analysis
  7. Prognostic factors and outcomes after definitive treatment of female urethral cancer: A population-based analysis
  8. Value of contrast-enhanced ultrasonography in prostate cancer
  9. The effect of ethnicity and sexual preference on prostate-cancer-related quality of life
  10. Face, content, and construct validation of the da Vinci Skills Simulator
  11. Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling
  12. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
  13. Costs of early adjuvant radiation therapy after radical prostatectomy: A decision analysis
  14. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer
  15. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy
  16. Postprostatectomy radiation therapy: An evidence-based review
  17. Post-prostatectomy image-guided radiation therapy: Evaluation of toxicity and inter-fraction variation using online cone-beam CT
  18. Screening for prostate cancer: the current evidence and guidelines controversy.
  19. Minimally invasive radical prostatectomy: Transition from pure laparoscopic to robotic-assisted radical prostatectomy
  20. Potential for dose escalation in the postprostatectomy setting with intensity-modulated radiation therapy: A dosimetric study using EORTC consensus guidelines for target volume contours

View All Publications